SPOTLIGHT -
EP. 1: Newly Diagnosed Advanced HCC: Frontline Therapy Overview
EP. 2: Selecting a Frontline TKI for Advanced HCC
EP. 3: Frontline I/O Therapy for HCC: Results From CheckMate459
EP. 4: Advanced HCC: Trial Data for Frontline Combination Therapy
EP. 5: Future of Frontline Combination Therapy in Advanced HCC
EP. 6: Second-Line Therapy for Advanced HCC: The RESOURCE Trial
EP. 7: Second-Line Therapy for Advanced HCC: The CELESTIAL Trial
EP. 8: Second-Line Use of I/O Therapy for Advanced HCC
EP. 9: Advanced HCC: Guiding Second-Line Therapy With AFP
EP. 10: Evolving HCC Treatment Paradigm: Combinations and Sequencing
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
